234 related articles for article (PubMed ID: 34150678)
21. Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy.
Pham H; Sharma P
Can J Urol; 2018 Apr; 25(2):9228-9237. PubMed ID: 29679999
[TBL] [Abstract][Full Text] [Related]
22. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
[TBL] [Abstract][Full Text] [Related]
23. Combined prostatic urethral lift and remodeling of the prostate and bladder neck: a modified transurethral approach in the treatment of symptomatic lower urinary tract obstruction.
Schoenthaler M; Sievert KD; Schoeb DS; Miernik A; Kunit T; Hein S; Herrmann TRW; Wilhelm K
World J Urol; 2018 Jul; 36(7):1111-1116. PubMed ID: 29450732
[TBL] [Abstract][Full Text] [Related]
24. Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms.
Magistro G; Chapple CR; Elhilali M; Gilling P; McVary KT; Roehrborn CG; Stief CG; Woo HH; Gratzke C
Eur Urol; 2017 Dec; 72(6):986-997. PubMed ID: 28734706
[TBL] [Abstract][Full Text] [Related]
25. [The UroLift® system for treatment of the benign prostatic syndrome (BPS)].
Westhofen T; Magistro G; Stief C; Gratzke C
Aktuelle Urol; 2018 Dec; 49(6):515-518. PubMed ID: 30522162
[TBL] [Abstract][Full Text] [Related]
26. Prostatic Urethral Lift: A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Bozkurt A; Karabakan M; Keskin E; Hirik E; Balci MB; Nuhoglu B
Urol Int; 2016; 96(2):202-6. PubMed ID: 26613256
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia.
Lokeshwar SD; Harper BT; Webb E; Jordan A; Dykes TA; Neal DE; Terris MK; Klaassen Z
Transl Androl Urol; 2019 Oct; 8(5):529-539. PubMed ID: 31807429
[TBL] [Abstract][Full Text] [Related]
28. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study.
Gratzke C; Barber N; Speakman MJ; Berges R; Wetterauer U; Greene D; Sievert KD; Chapple CR; Patterson JM; Fahrenkrug L; Schoenthaler M; Sonksen J
BJU Int; 2017 May; 119(5):767-775. PubMed ID: 27862831
[TBL] [Abstract][Full Text] [Related]
29. Do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatment.
Lebdai S; Chevrot A; Doizi S; Pradere B; Delongchamps NB; Benchikh A; Cornu JN; Della Negra E; Fourmarier M; Misraï V; Theveniaud PE; Descazeaud A; Robert G;
World J Urol; 2019 Feb; 37(2):299-308. PubMed ID: 29967947
[TBL] [Abstract][Full Text] [Related]
30. Recent developments in the surgical management of benign prostatic hyperplasia.
Jepsen JV; Bruskewitz RC
Urology; 1998 Apr; 51(4A Suppl):23-31. PubMed ID: 9586593
[TBL] [Abstract][Full Text] [Related]
31. 24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham.
Rukstalis D; Rashid P; Bogache WK; Tutrone RF; Barkin J; Chin PT; Woo HH; Cantwell AL; Cowan BE; Bolton DM
BJU Int; 2016 Oct; 118 Suppl 3():14-22. PubMed ID: 27684483
[TBL] [Abstract][Full Text] [Related]
32. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
[TBL] [Abstract][Full Text] [Related]
33. Office-based therapies for benign prostatic hyperplasia: a review and update.
Das AK; Leong JY; Roehrborn CG
Can J Urol; 2019 Aug; 26(4 Suppl 1):2-7. PubMed ID: 31481142
[TBL] [Abstract][Full Text] [Related]
34. Management of Benign Prostatic Hyperplasia Larger than 100 ml: Simple Open Enucleation Versus Transurethral Laser Prostatectomy.
Elkoushy MA; Elhilali MM
Curr Urol Rep; 2016 Jun; 17(6):44. PubMed ID: 27048160
[TBL] [Abstract][Full Text] [Related]
35. Beyond medications: office-based procedures for benign prostatic obstruction.
Tran PU; Chung ASJ
World J Urol; 2019 Jun; 37(6):1023-1027. PubMed ID: 31037402
[TBL] [Abstract][Full Text] [Related]
36. Three year results of the prostatic urethral L.I.F.T. study.
Roehrborn CG; Rukstalis DB; Barkin J; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Cantwell AL; McVary KT; Te AE; Gholami SS; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rashid P
Can J Urol; 2015 Jun; 22(3):7772-82. PubMed ID: 26068624
[TBL] [Abstract][Full Text] [Related]
37. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
Woo HH; Chin PT; McNicholas TA; Gill HS; Plante MK; Bruskewitz RC; Roehrborn CG
BJU Int; 2011 Jul; 108(1):82-8. PubMed ID: 21554526
[TBL] [Abstract][Full Text] [Related]
38. Prostatic hydroablation (Aquablation): A new effective ultrasound guided robotic waterjet ablative surgery for treatment of benign prostatic hyperplasia.
Lim Ng K; Barber N
Arch Esp Urol; 2019 Oct; 72(8):786-793. PubMed ID: 31579037
[TBL] [Abstract][Full Text] [Related]
39. Prostatic Urethral Lift: A Unique Minimally Invasive Surgical Treatment of Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Roehrborn CG
Urol Clin North Am; 2016 Aug; 43(3):357-69. PubMed ID: 27476128
[TBL] [Abstract][Full Text] [Related]
40. Prostatic urethral lift: a novel approach for managing symptomatic BPH in the aging man.
Rukstalis DB
Can J Urol; 2015 Oct; 22 Suppl 1():67-74. PubMed ID: 26497346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
